lactic acid has been researched along with Autoimmune Diseases in 11 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We measured concentrations of kynurenine (Kyn) and tryptophan (Trp) in 221 cerebrospinal fluid samples from patients with bacterial and viral (due to herpes simplex, varicella zoster, and enteroviruses) meningitis/encephalitis, neuroborreliosis, autoimmune neuroinflammation (due to anti-N-methyl-D-aspartate receptor [NMDA] encephalitis and multiple sclerosis), and noninflamed controls (ie, individuals with Bell palsy, normal pressure hydrocephalus, or Tourette syndrome)." | 7.91 | Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections. ( Kaever, V; Kuhn, M; Müller-Vahl, K; Novoselova, N; Pessler, F; Seegers, L; Skripuletz, T; Stangel, M; Sühs, KW; Trebst, C, 2019) |
| "The therapeutic effects of betamethasone phosphate (BP) encapsulated in biocompatible and biodegradable blended nanoparticles of poly(lactic acid) (PLA) homopolymers and PEG-block-PLA copolymers (stealth nanosteroids) were examined in an experimental autoimmune uveoretinitis (EAU) model in Lewis rats." | 7.77 | Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis. ( Akiyama, G; Higaki, M; Ishihara, T; Sakai, T; Tsuneoka, H, 2011) |
| " In this study, we evaluated the effects of intravenously administered poly(lactic acid) nanoparticles encapsulating betamethasone phosphate (BP-PLA NPs) on experimental autoimmune uveoretinitis (EAU) in Lewis rats." | 7.73 | Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. ( Higaki, M; Ishihara, T; Kitahara, K; Kohno, H; Matsushima, M; Mizushima, Y; Saito, S; Sakai, T, 2006) |
| "We measured concentrations of kynurenine (Kyn) and tryptophan (Trp) in 221 cerebrospinal fluid samples from patients with bacterial and viral (due to herpes simplex, varicella zoster, and enteroviruses) meningitis/encephalitis, neuroborreliosis, autoimmune neuroinflammation (due to anti-N-methyl-D-aspartate receptor [NMDA] encephalitis and multiple sclerosis), and noninflamed controls (ie, individuals with Bell palsy, normal pressure hydrocephalus, or Tourette syndrome)." | 3.91 | Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections. ( Kaever, V; Kuhn, M; Müller-Vahl, K; Novoselova, N; Pessler, F; Seegers, L; Skripuletz, T; Stangel, M; Sühs, KW; Trebst, C, 2019) |
| "The therapeutic effects of betamethasone phosphate (BP) encapsulated in biocompatible and biodegradable blended nanoparticles of poly(lactic acid) (PLA) homopolymers and PEG-block-PLA copolymers (stealth nanosteroids) were examined in an experimental autoimmune uveoretinitis (EAU) model in Lewis rats." | 3.77 | Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis. ( Akiyama, G; Higaki, M; Ishihara, T; Sakai, T; Tsuneoka, H, 2011) |
| " In this study, we evaluated the effects of intravenously administered poly(lactic acid) nanoparticles encapsulating betamethasone phosphate (BP-PLA NPs) on experimental autoimmune uveoretinitis (EAU) in Lewis rats." | 3.73 | Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. ( Higaki, M; Ishihara, T; Kitahara, K; Kohno, H; Matsushima, M; Mizushima, Y; Saito, S; Sakai, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Sanmarco, LM | 1 |
| Rone, JM | 1 |
| Polonio, CM | 1 |
| Fernandez Lahore, G | 1 |
| Giovannoni, F | 1 |
| Ferrara, K | 1 |
| Gutierrez-Vazquez, C | 1 |
| Li, N | 1 |
| Sokolovska, A | 1 |
| Plasencia, A | 1 |
| Faust Akl, C | 1 |
| Nanda, P | 1 |
| Heck, ES | 1 |
| Li, Z | 1 |
| Lee, HG | 1 |
| Chao, CC | 1 |
| Rejano-Gordillo, CM | 1 |
| Fonseca-Castro, PH | 1 |
| Illouz, T | 1 |
| Linnerbauer, M | 1 |
| Kenison, JE | 1 |
| Barilla, RM | 1 |
| Farrenkopf, D | 1 |
| Stevens, NA | 1 |
| Piester, G | 1 |
| Chung, EN | 1 |
| Dailey, L | 1 |
| Kuchroo, VK | 1 |
| Hava, D | 1 |
| Wheeler, MA | 1 |
| Clish, C | 1 |
| Nowarski, R | 1 |
| Balsa, E | 1 |
| Lora, JM | 1 |
| Quintana, FJ | 1 |
| Marin, E | 1 |
| Bouchet-Delbos, L | 1 |
| Renoult, O | 1 |
| Louvet, C | 1 |
| Nerriere-Daguin, V | 1 |
| Managh, AJ | 1 |
| Even, A | 1 |
| Giraud, M | 1 |
| Vu Manh, TP | 1 |
| Aguesse, A | 1 |
| Bériou, G | 1 |
| Chiffoleau, E | 1 |
| Alliot-Licht, B | 1 |
| Prieur, X | 1 |
| Croyal, M | 1 |
| Hutchinson, JA | 1 |
| Obermajer, N | 1 |
| Geissler, EK | 1 |
| Vanhove, B | 1 |
| Blancho, G | 1 |
| Dalod, M | 1 |
| Josien, R | 1 |
| Pecqueur, C | 1 |
| Cuturi, MC | 1 |
| Moreau, A | 1 |
| Christofi, M | 1 |
| Le Sommer, S | 1 |
| Mölzer, C | 1 |
| Klaska, IP | 1 |
| Kuffova, L | 1 |
| Forrester, JV | 1 |
| Sühs, KW | 1 |
| Novoselova, N | 1 |
| Kuhn, M | 1 |
| Seegers, L | 1 |
| Kaever, V | 1 |
| Müller-Vahl, K | 1 |
| Trebst, C | 1 |
| Skripuletz, T | 1 |
| Stangel, M | 1 |
| Pessler, F | 1 |
| Yang, Z | 1 |
| Matteson, EL | 1 |
| Goronzy, JJ | 1 |
| Weyand, CM | 1 |
| Cano-Garrido, O | 1 |
| Seras-Franzoso, J | 1 |
| Garcia-Fruitós, E | 1 |
| Pucino, V | 1 |
| Bombardieri, M | 1 |
| Pitzalis, C | 1 |
| Mauro, C | 1 |
| Basarkar, A | 1 |
| Singh, J | 1 |
| Sakai, T | 2 |
| Ishihara, T | 2 |
| Higaki, M | 2 |
| Akiyama, G | 1 |
| Tsuneoka, H | 1 |
| Kohno, H | 1 |
| Saito, S | 1 |
| Matsushima, M | 1 |
| Mizushima, Y | 1 |
| Kitahara, K | 1 |
| Korn, T | 1 |
| Rao, M | 1 |
| Magnus, T | 1 |
4 reviews available for lactic acid and Autoimmune Diseases
| Article | Year |
|---|---|
T-cell metabolism in autoimmune disease.
Topics: Adenosine Triphosphate; Arthritis, Rheumatoid; Autoimmune Diseases; Humans; Lactic Acid; Lupus Eryth | 2015 |
Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.
Topics: Autoimmune Diseases; Drug Delivery Systems; Gastrointestinal Tract; Genetic Vectors; Gram-Positive B | 2015 |
Lactate at the crossroads of metabolism, inflammation, and autoimmunity.
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Autoimmunity; Energy Metabolism; Humans; Immune | 2017 |
Autoimmune modulation of astrocyte-mediated homeostasis.
Topics: Animals; Antigen Presentation; Astrocytes; Autoimmune Diseases; Autoimmunity; Biological Transport, | 2007 |
7 other studies available for lactic acid and Autoimmune Diseases
| Article | Year |
|---|---|
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells.
Topics: Autoimmune Diseases; Autoimmunity; Central Nervous System; Dendritic Cells; Feedback, Physiological; | 2023 |
Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis.
Topics: Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Female; | 2019 |
Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects.
Topics: Animals; Antigens, Bacterial; Autoimmune Diseases; B7-2 Antigen; Bone Marrow Cells; CD4-Positive T-L | 2021 |
Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Biomarkers; Central Nervous System | 2019 |
Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice.
Topics: Animals; Autoimmune Diseases; Blood Glucose; Buffers; Diabetes Mellitus; Drug Delivery Systems; Exci | 2009 |
Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.
Topics: Animals; Autoimmune Diseases; Betamethasone; Biocompatible Materials; Biological Availability; Delay | 2011 |
Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Betamethasone; Choroid; Delayed-Action Prepa | 2006 |